Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Cholan-24-oic acid, 3-[(2S)-2-amino-3-carboxy-1-oxopropoxy]-, (3α,5β)- | 881179-02-8 | 98.0% | 491.66 | 10 MG
SDP

Catalog No. 5000436434
Encompass_Preferred

Lith-O-Asp is a sialyltransferase (ST) inhibitor with IC50 values ranging from 12-37 μM. It has been shown to decrease the activity of both α-2,3- and α-2,6-sialyltransferases, thereby inhibiting the transfer of sialic acids to targeted glycoproteins. Research indicates that Lith-O-Asp may suppress cancer angiogenesis and metastasis pathways, as demonstrated by fewer lung metastases in treated mice compared to controls.

  • Sialyltransferase (ST) inhibitor.
  • Inhibits the activities of ST3Gal I, ST3Gal III, and ST6GalI.
  • Decreases expression of cell surface α-2,3- and α-2,6-sialylated antigens.
  • Suppresses cancer angiogenesis and metastasis pathways.

Catalog No. 50-004-36434 Supplier Medchemexpress LLC Supplier No. HY11241510MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Lith-O-Asp is a sialyltransferase (ST) inhibitor with IC50 values ranging from 12-37 μM. It has been shown to decrease the activity of both α-2,3- and α-2,6-sialyltransferases, thereby inhibiting the transfer of sialic acids to targeted glycoproteins. Research indicates that Lith-O-Asp may suppress cancer angiogenesis and metastasis pathways, as demonstrated by fewer lung metastases in treated mice compared to controls.

  • Sialyltransferase (ST) inhibitor.
  • Inhibits the activities of ST3Gal I, ST3Gal III, and ST6GalI.
  • Decreases expression of cell surface α-2,3- and α-2,6-sialylated antigens.
  • Suppresses cancer angiogenesis and metastasis pathways.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.